Gabriel Mecklenburg

Gabriel Mecklenburg

About

Detail

Co-founder & CTO
San Francisco, California, United States

Timeline

work
Job
school
Education
folder
Project

Résumé

Jobs verified_user 0% verified
  • Hinge Health
    Co-founder & CTO
    Hinge Health
    Jan 2025 - Current (1 year 6 months)
  • Pelago
    Board Member
    Pelago
    Jan 2022 - Current (4 years 6 months)
    Pelago, formerly Quit Genius, is the world’s leading virtual clinic for substance use management. We are transforming substance use support—from prevention to treatment—delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, or opioids. Our solution gives employers and payers the means to offer on-demand, personalized support to members seeking to live healthier lives. Pelago’s cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. To date, Pelago has helped more than
  • Hinge Health
    Co-founder, Executive Chairman
    Hinge Health
    Jan 2021 - Current (5 years 6 months)
    Hinge Health is creating a new health care system, built around you. Accessible to 25 million members across more than 1,200 customers, Hinge Health is the #1 digital clinic for joint and muscle pain, delivering superior member outcomes and proven claims reductions. We pair the industry’s most advanced motion technology and wearable pain relief with a complete clinical care team of physical therapists, physicians, and board-certified health coaches to help people move beyond pain and reduce surgeries and opioid use. Hinge Health’s HingeConnect integrates with 1 million+ in-person providers to enable earlier interventions for avoidable MSK surgeries. Learn more at http://www.hingehealth.com. Hinge Health has raised close to $1B to date with
  • Hinge Health
    Co-founder, Chief Operating Officer
    Hinge Health
    Oct 2014 - Jan 2021 (6 years 4 months)
  • Marblar
    Co-founder & COO
    Marblar
    Jun 2012 - Oct 2014 (2 years 5 months)
    Marblar is a product development company, consisting of a small but potent team of designers, engineers, scientists, and developers. We're developing a product to tackle a key big problem in the healthcare space. We're VC-funded by IP Group plc, a UK-based investor focusing on technology commercialisation.
  • Oxbridge Biotech Roundtable
    Chief Operating Officer
    Oxbridge Biotech Roundtable
    Dec 2011 - May 2014 (2 years 6 months)
    The Oxbridge Biotech Roundtable is a global organisation that bridges the gap between academia and industry in the life sciences, with a mission to move ideas forward. Joining a few months after its inception in 2011, I was initially responsible for leading the fledgling London chapter. For the remainder of my tenure I was responsible for operations of the organisation as it grew to >20,000 members in the US, UK, Singapore and Hong Kong (as of mid-2014).
Education verified_user 0% verified
  • Imperial College London
    Master of Philosophy (MPhil, Bioengineering
    Imperial College London
    Jan 2011 - Dec 2014 (4 years)
    Thesis title: Functionalised polymer fibres for orthopaedic interfacial tissue engineering and other biomedical applications. Supervised by Prof Molly Stevens and Dr Iain Dunlop.
  • University of Cambridge
    Master's Degree, Materials Science
    University of Cambridge
    Jan 2006 - Dec 2010 (5 years)
    MA/MSc Natural Sciences degree in Materials Science, with additional focus on Chemistry. Graduated first in the year.
Projects (professional or personal) verified_user 0% verified
  • O
    OneStart £100K Business Plan Competition
    Dec 2012 - Current (13 years 7 months)
    OneStart is open to aspiring life science entrepreneurs aged 35 and younger, who are living or working in the UK or Europe (you do not have to be a UK or EU citizen). The competition will be run in stages and covers four tracks: drug discovery, medical devices, diagnostics and health IT. Entrants can join individually or as a team, and are encouraged to recruit other scientists and even business students. Teams will be given access to mentors and other resources, and have the opportunity to network with leading pharmaceutical companies, venture capitalists and advisory firms. A judging panel of experts will select the ultimate winner. The prize will be awarded to the most compelling idea with the potential to impact the lives of patients. T
This is a community-created genome.